Заглавие журнала :STROKE -2003г. т.34,N 2 Интересные статьи : Hochinski V. Advances in Stroke 2002 : Introduction/ V. Hochinski (стр.323) Moskowitz M.A. Neurogenesis and apoptotic cell death/ M.A. Moskowitz (стр.324-326) Faraci F.M. Vascular protection/ F.M. Faraci (стр.327-329) Goldberg M.P. New light on white matter/ M.P. Goldberg, B.R. Ransom (стр.330-332) Spence J.D. Infection, inflammation, and atherosclerosis/ J.D. Spence, J. Norris (стр.333-334) Iadecola C. Converging pathogenic mechanisms in vascular and neurodegenerative dementia/ C. Iadecola, P.B. Gorelick (стр.335-337) Hurn P.D. Estrogen and stroke/ P.D. Hurn, L.M. Brass (стр.338-341) Alberts M.J. Stroke genetics update/ M.J. Alberts (стр.342-344) Warach S. Stroke neuroimaging/ S. Warach (стр.345-347) Kennedy J. Ever decreasing circles : Advances in antiplatelet therapy and anticoagulation/ J. Kennedy, A.M. Buchan (стр.348-350) Kaste M. Statins in threatened stroke/ M. Kaste (стр.351-353) Hankey G.J. Angiotensin-converting enzyme inhibitors for stroke prevention/ G.J. Hankey (стр.354-356) Pelz D.M. Advances in interventional neuroradiology/ D.M. Pelz (стр.357-358) Fisher M. Emerging therapies for acute ischemic stroke/ M. Fisher, T.G. Brott (стр.359-361) Hanley D.F. Review of critical care and emergency approaches to stroke/ D.F. Hanley (стр.362-364) Teasell R. Stroke recovery and rehabilitation/ R. Teasell (стр.365-366) Goldstein L.B. Prevention and health services delivery/ L.B. Goldstein (стр.367-369) Matchar D.B. Health policy in stroke: Translating what we know into what we do/ D.B. Matchar (стр.370-371) Donnan G.A. Controversy: The essence of medical debate/ G.A. Donnan, S.M. Davis (стр.372-373) Letters to the editor (стр.374-378) Risk of stroke associated with nonsteroidal anti-inflammatory drugs (стр.379-385) Qureshi A.I. Editorial comment : Nonsteroidal anti-inflammatory drugs and the risk of intracerebral hemorrhage/ A.I. Qureshi (стр.385-386) Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage (стр.387-391) Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study (стр.392-396) Genetic and environmental contributions to atherosclerosis phenotypes in men and women (стр.397-401) Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis (стр.402-407) Radical differences in thoracic aorta atherosclerosis among ischemic stroke patients (стр.408-412) Atrial fibrillation and the prothrombotic state in the elderly (стр.413-417) Mortality from cerebrovascular disease in a cohort of 23000 patients with insulin-treated diabetes (стр.418-421) Family history and risk of subarachnoid hemorrhage (стр.422-426) Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage (стр.427-433) Bhardwaj A. Editorial comment : SAH-Induced cerebral vasospasm: Unraveling molecular mechanisms of a complex disease/ A. Bhardwaj (стр.432-433) Watanabe Y. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage/ Y. Watanabe, Y. Chu, J.J. Andresen (стр.434-440) Kapeller P. Visual rating of age-related white matter changes on magnetic resonance imaging/ P. Kapeller, R. Barber, R.J. Vermeulen (стр.441-445) Rosengarten B. Effects of acute hyperhomocysteinemia on the neurovascular coupling mechanism in healthy young adults/ B. Rosengarten, S. Osthaus, D. Auch (стр.446-451) Infection and risk of ischemic stroke (стр.452-457) Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator (стр.458-463) Kent D.M. Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset ?/ D.M. Kent, R. Ruthazer, H.P. Selker (стр.464-467) Wang X. Inhibition of factor Xa reduces ischemic brain damage after thromboembolic stroke in rats/ X. Wang, L. Xu, H. Wang (стр.468-474) Martinsson L. Safety of dexamphetamine in acute ischemic stroke / L. Martinsson, G. Wahlgren (стр.475-481) Tolerability of NXY-059 at higher target concentrations in patients with acute stroke (стр.482-487) Physical and social functioning after stroke (стр.488-493) Risk factors for falling in home-dwelling older women with stroke (стр.494-501) Gustafson Y. Editorial comment: Falls and injuries after stroke: Time for action !/ Y. Gustafson (стр.500-501) Measuring longitudinally the metabolic demands of stroke patients (стр.502-507) Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery (стр.508-513) Rothwell P.M. Reanalysis of the final results of the European Carotid Surgery Trial/ P.M. Rothwell, S.A. Gutnikov, C.P. Warlow (стр.514-523) Barth A. Patient selection for carotid endarterectomy/ A. Barth, C. Bassetti (стр.524-527) Teng J. Costs and caregiver consequences of early supported discharge for stroke patients/ J. Teng, N.E. Mayo, E. Latimer (стр.528-536) Liberatore G.T. Vampire bat salivary plasminogen activator (Desmoteplase)/ G.T. Liberatore, A. Samson, C. Bladin (стр.537-543) Ujiie H. Essential role of Gap junctions in NO- and prostanoid-independent relaxations evoked by acetylcholine in rabbit intracerebral arteries/ H. Ujiie, A.T. Chaytor, L.M. Bakker (стр.544-550) Gertz K. Withdrawal of statin treatment abrogates stroke protection in mice/ K. Gertz, U. Laufs, Ute Lindauer (стр.551-557) Chang C.-F. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats/ C.-F. Chang, S.-Z. Lin, Y.-H. Chiang (стр.558-564) Atiya M. Interobserver agreement in the classification of stroke in the women's health study/ M. Atiya, T. Kurth, K. Berger (стр.565-567) Kasner S.E. Modified national institutes of health stroke scale can be estimated from medical records/ S.E. Kasner, B.L. Cucchiara, M.L. McGarvey (стр.568-570) Hyperbaric oxygen therapy in acute ischemic stroke (стр.571-574) Schellinger P.D. Imaging-based decision making in thrombolytic therapy for ischemic stroke/ P.D. Schellinger, J.B. Fiebach, W. Hacke (стр.575-582) Rother J. Editorial comment: Imaging-guided extension of the time window: Ready for application in experienced stroke centers ?/ J. Rother (стр.582-583) Bowler J.V. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease/ J.V. Bowler (стр.584-586) Kwan J. In-Hospital care pathways for stroke : A cochrane systematic review/ J. Kwan, P. Sandercock (стр.587-588) Major ongoing stroke trials (стр.e1) Интересные статьи : Доп.точки доступа: Hochinski, V.; Moskowitz, M. A.; Faraci, F. M.; Goldberg, M. P.; Spence, J. D.; Iadecola, C.; Hurn, P. D.; Alberts, M. J.; Warach, S.; Kennedy, J.; Kaste, M.; Hankey, G. J.; Pelz, D. M.; Fisher, M.; Hanley, D. F.; Teasell, R.; Goldstein, L. B.; Matchar, D. B.; Donnan, G. A.; Qureshi, A. I.; Bhardwaj, A.; Watanabe, Y.; Kapeller, P.; Rosengarten, B.; Kent, D. M.; Wang, X.; Martinsson, L.; Gustafson, Y.; Rothwell, P. M.; Barth, A.; Teng, J.; Liberatore, G. T.; Ujiie, H.; Gertz, K.; Chang, C. -F.; Atiya, M.; Kasner, S. E.; Schellinger, P. D.; Rother, J.; Bowler, J. V.; Kwan, J.; Ransom, B. R.; Norris, J.; Gorelick, P. B.; Brass, L. M.; Buchan, A. M.; Brott, T. G.; Davis, S. M.; Chu, Y.; Barber, R.; Osthaus, S.; Ruthazer, R.; Xu, L.; Wahlgren, G.; Gutnikov, S. A.; Bassetti, C.; Mayo, N. E.; Samson, A.; Chaytor, A. T.; Laufs, U.; Lin, S. -Z.; Kurth, T.; Cucchiara, B. L.; Fiebach, J. B.; Sandercock, P.; Andresen, J. J.; Vermeulen, R. J.; Auch, D.; Selker, H. P.; Wang, H.; Warlow, C. P.; Latimer, E.; Bladin, C.; Bakker, L. M.; Lindauer Ute; Chiang, Y. -H.; Berger, K.; McGarvey, M. L.; Hacke, W.